Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
--
More ▼
Announcements
- IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares
- IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY
- IMCD reports EBITA of EUR 403 million in the first nine months of 2024
- IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America
- IMCD successfully issues a EUR 500 million rated bond
- IMCD reports EBITA of EUR 270 million in the first half of 2024
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
More ▼